Zydelig |
CLL patients |
Revlimid® (Lenalidomide) |
Adult patients Multiple Myeloma, Myelodysplastic syndromes and Mantle cell lymphoma |
Imnovid® (pomalidomide) |
Adult patients with relapsed and refractory multiple myeloma |
VIDAZA® (azacitidine) |
Adult patients not eligible for haematopoietic stem cell transplantations (HSCT) |
Evoltra |
Paediatric patients (Acute Lymphoblastic Leukemia) |
MabCampath |
Patients with B-cell chronic lymphocytic leukaemia (B-CLL) |
Gazyvaro (obinutuzumab) |
Adult patients with Chronic Lymphocytic Leukaemia (CLL) |
Soliris |
Adults and children with Paroxysmal nocturnal haemoglobinuria (PNH) |
Ninlaro |
Adult patients with multiple myeloma who have received at least one prior therapy |
ADCETRIS® (brentuximab vedotin) |
Adult patients with relapsed or refractory CD30+ Hodgkin lymphoma (HL) |